Literature DB >> 27081467

Assessment of expressions of Bcl-XL, b-FGF, Bmp-2, Caspase-3, PDGFR-α, Smad1 and TGF-β1 genes in a rat model of lung ischemia/reperfusion.

Hasan Şimşek1, Şeniz Demiryürek2, Tuncer Demir2, Hüsne Didem Atabay2, Ali Osman Çeribasi3, Recep Bayraktar4, Davut Sinan Kaplan2, Serdar Öztuzcu4, Beyhan Cengiz5.   

Abstract

OBJECTIVES: Ischemia is described as organs and tissues are destitute of oxygen due to decreased arterial or venous blood flow. Many mechanisms play role in cell death happened as a consequence of a new blood flow is needed for both cell regeneration and to clean toxic metabolites during ischemia and later. Lung damage induced by ischemia/reperfusion (I/R) is a frequent problem in lung transplantation. Apoptosis (programmed cell death) is known as cell suicide, and plays a key role in embryonic developmental and in maintain adult tissue's life.
MATERIALS AND METHODS: It is investigated expressions of Smad1, Bmp-2, Bcl-XL, b-FGF, Caspase-3, TGF-β1, PDGFR-α genes for molecular changes in lung tissues, after I/R is formed, in this study. For this, we included 40 Wistar albino rats to this study and divided 4 groups (n=10). The Groups were determined as Control (C), Group 1= 1 hr ischemia (I), Group 2= 1 hr ischemia+2 hr reperfusion (I+2R), Group 3= 1 hr ischemia+4 hr reperfusion (I+4R). Besides, molecular analysis and histopathologic examinations of tissues were performed, and the results were evaluated by normalization and statistics analysis.
RESULTS: We have found a significant increase in expression of Bcl-XL (P=0.046) and Caspase-3 (P=0.026) genes of group 1, and it was not monitored any significant difference in Group 2 and Group 3. In all groups, the changes in b-FGF (P=0.087), Bmp-2 (P=0.457), TGF-β1 (P=0.201) and PDGFR-α (P=0.116) were not significant compared to control group. We did not see any mRNA expression of Smad1 gene in all groups include control.
CONCLUSION: These findings suggest that I/R injury may trigger apoptotic mechanism in lung.

Entities:  

Keywords:  Apoptosis; Growth factors; Ischemia/reperfusion; Lung

Year:  2016        PMID: 27081467      PMCID: PMC4818370     

Source DB:  PubMed          Journal:  Iran J Basic Med Sci        ISSN: 2008-3866            Impact factor:   2.699


Introduction

Ischemia/reperfusion (I/R) is characterized by histopathological changes due to the fact that it cause lung edema and neutrophil extravasation and some changes in vascular permeability. These changes are mostly formed by reactive oxygen species (ROS) generated during reperfusion (1). Membrane lipids, proteins, nucleic acids and deoxyribonucleic acids are most sensitive ones of cell components to reperfusion damage (2). Pulmonary dysfunction caused by I/R damage is one of the important problems in lung transplantation (3). After I/R damage, intense inflammatory response, endothelial injury, neutrophil infiltration and pulmonary edema are occurred in lung tissue (4). Pulmonary vascular cell injury is formed as a result of I/R damage or chronic hypoxia (5). The function of reperfusion in ischemic lung tissue is like double-edged sword, so both reperfusion is needed to keep alive the cell and it may triggers a chain of events, like increased microvascular permeability, pulmonary vascular resistance, pulmonary edema, disturbed oxygenation and pulmonary hypertension, may cause serious I/R damage (6). I/R applications may trigger one of the three programmed cell death, apoptosis, autophagy and necrosis (7). First of these mechanism is apoptosis, the best known. Apoptosis was described by Kerr et al (8). in 1972. This mechanism provides digestion of damaged cells and is characterized by caspase activation (5). Aim of this study is to investigate whether I/R induces apoptosis or not in lung, also is to shed light on which pathway is used by apoptosis in lung tissues when it is stimulated by I/R. For this purpose, we have selected some genes; apoptotic gene (Caspase-3), anti-apoptotic gene (Bcl-XL), growth factor genes (b-FGF, TGF-β1), growth factor receptor gene (PDGFR-α), and Bmp-2 signaling pathway genes (Bmp-2, Smad1) are important to understand apoptosis and its pathway. Caspases are inactive in cells, and when a caspase is activated, it starts a cascade to activates other pro-caspase (9). Caspase-3 is the most important one among the caspases is, it is also known as hangman caspase and is activated by initiator caspases (caspase-8, 9 and 10), and by the other main components, like B-cell lymphoma 2 (Bcl-2) protein family, determine the place of cells between death and life. This family have both proapoptotic and antiapoptotic members (10), and the best known member of this family is Bcl-XL protein (11). b-FGF is known as premotor gene of angiogenesis and lymph angiogenesis and has role in cell migration, growth and differentiation (12). TGF family has 40 members with the inclusion of bone morphogenetic protein family (BMP), biggest subfamily in this group and have many functions in apoptosis (13), and is responsible for cell proliferation, differentiation, motility and extracellular matrix production (14). Smad family members have been classified into three subgroups, receptor-regulated Smads (R-Smads), common mediator Smads (Co-Smads) and inhibitory Smad proteins. Smad1 is member of R-Smads, and activated by BMP ligands (15). Platelet derived growth factor (PDGF) isoforms takes effect by binding -α and –β (PDGFR-α and PDGFR-β) receptors, and the main function is to stimulate growth of mesenchymal cells, also efficient on motility and survival (16).

Materials and Methods

The animals

In the study, 40 adult Wistar albino rats with a weight of 250–300 g body mass and used. Before the study, all animals were kept in the laboratory so as to orientate them to the laboratory conditions including 50-60 % humidity, 12 hr light and 12 hr dark cycle and 22-24 °C temperature. All studies were carried out in accordance with the National Institutes of Health guidelines on animal care and with the approval of the Ethics Committee of the Gaziantep University, Gaziantep, Turkey.

I/R model

In order to induce lung ischemia, atraumatic clamps were used (Picture 1).
Picture 1

Experimental lung ischemia model. 1) incision was performed from manubrium sterni to xiphoid. 2) left pulmonary artery was isolated and clamped with an atraumatic microvascular clamp during 60 min

Experimental lung ischemia model. 1) incision was performed from manubrium sterni to xiphoid. 2) left pulmonary artery was isolated and clamped with an atraumatic microvascular clamp during 60 min

Control group

Anything did to this group. Animals were anaesthetized and tissue samples were got out.

Group 1 (I)

Left pulmonary artery was clamped with atraumatic clamp during 1 hr. Then the tissue samples were got out from lung.

Group 2 (I/2R)

Left pulmonary artery was clamped with atraumatic clamp during 1 hr. Then the clamp was opened and reperfusion was allowed during 2 hr. At the end of 3 hr, tissue samples were got out from lung.

Group 3 (I/4R)

Left pulmonary artery was clamped with atraumatic clamp during 1 hr. Then the clamp was opened and reperfusion was allowed during 4 hr. At the end of 5 hr, tissue samples were got out from lung. Before the surgery, the animals were anesthetized with xylazine hydrochloride 5 mg/kg and ketamine hydrochloride 35 mg/kg IP injection, and after the surgery, lung tissues were divided into 2 with a scalpel. One part was kept in 10 % formalin solution for histopathological investigation, and the remaining parts were kept in nitrogen tank for further molecular studies.

Tissue homogenization

Qiagen TissueLyser LT machine (Catalog No:85600, Mainz, Germany) and QIAzol Lysis Reagent (Qiagen, Catalog No:79306, Mainz, Germany) were used to disintegrate and to homogenizate the tissue samples.

Total RNA isolation and cDNA conversion

Roche High Pure RNA Tissue Kit’s (Product No. 12033674001, Mannheim, Germany) protocol was used to isolate total RNA from tissue samples. Then, Ipsogen RT Kit (Catalog no: 679913, Qiagen, Hilden, Germany) was used to convert mRNA isolated to cDNA.

cDNA concentration measurement

Epoch (BioTek, Winooski VT, USA) measurement machine was used to measure the concentration of all cDNA samples, and the last concentrations were adjusted 50 ng/µl.

Reverse transcription-polymerase chain reaction (RT-PCR)

RT-PCR conditions specified for each gene were performed with GeneAmp® PCR System 9700 (Applied Biosystem, Singapore) PCR device. mRNA levels of b-FGF (Sense: 5’-GGCTATGAAGGAA-GATGGAC-3’ Anti-sense: 5’-GTTCGTTTCAGTGCC-ACA-3’), Bcl-XL (Sense: 5’-AGGCTGGCGATGAGTTT-GAA-3’ Anti-sense: 5’-TGAAACGCTCCTGGCCTTTC-3’), Bmp-2 (Sense: 5’-AAGGCACCCTTTGTATGTGG-3’ Anti-sense: 5’-CATGCCTTAGGGATTTTGGA-3’), Caspase-3 (Sense: 5’-GACTGCGGTATTGAGACAGA-3’ Anti-sense: 5’-CGAGTGAGGATGTGCATGAA-3’), PDGFR-α (Sense: 5’-GTCCAGGTGAGGTTAGAGG-3’ Anti-sense: 5’- CACGGAGGAGAACAAAGAC-3’), Smad-1 (Sense: 5’- CCGCCTGCTTACCTGCCTCCTGAA-3’ Anti-sense: 5’-GAACGCTTCGCCCACACGGTTGT-3’), TGF-β1 (Sense: 5’-GCTAATGGTGGACCGCAACAAC-3’ Anti-sense: 5’-CAGCAGCCGGTTACCAAG-3’) were studied by RT-PCR using primer sets. Amounts of PCR products were normalized by using β-actin (Sense: 5’-AGGCCAACCGTGAAAAGATG-3’ Anti-sense: 5’-ACCAGAGGCATACAGGGACAA-3’) as housekeeping gene. cDNA was denatured at 94 °C for 4 min, annealed at 60 °C for 30 sec (bFGF), at 60 °C for 30 sec (Bcl-XL), at 60 °C for 30 sec (Bmp-2), at 59.1 °C for 45 sec (Caspase-3), at 59.1 °C for 30 sec (PDGFR- α), at 71 °C for 45 sec (Smad-1), at 60.9 °C for 30 sec (TGF-β1). RT-PCR mixtures (8 µl) were electrophoresed on a 2% agarose gel, which was subsequently stained with 0.5 ml/ml ethidium bromide. Gels were scanned on an imaging analyzer (Picture 2), and the corresponding band densities were measured with imageJ program.
Picture 2

Agarose gel electrophoresis image of the Bmp-2 gene. L: left lung tissue; R: right lung tissue; C: control

Agarose gel electrophoresis image of the Bmp-2 gene. L: left lung tissue; R: right lung tissue; C: control

Histopathology

The lung specimens dehydrated and embedded in paraffin, and sectioned at 5 μm thickness. The samples were stained with Hematoxylin-Eosin (H-E) and analyzed under light microscopy.

Statistical analysis

All the values were calculated as mean ± standard deviation by SPSS for Windows version 22.0. for all the evaluated genes. Kruskal-wallis test and Dunn’s multiple comparison were used to compare the variables. P<0.05 was considered to be statistically significant.

Results

Gene expression results

The results of mRNA expressions are shown in Figure 1. While there is a significant increase in Bcl-XL
Figure 1

Gene expressions of groups. Caspase-3 (P=0.026) and Bcl-XL (P=0.046) are statistically significant increase in group 1 (*=P<0.05)

Gene expressions of groups. Caspase-3 (P=0.026) and Bcl-XL (P=0.046) are statistically significant increase in group 1 (*=P<0.05) (P=0.046) and Caspase-3 (P=0.026) genes in ischemia group, there were not significant differences in groups 2 and 3 (Bcl-XL (P=0.046) and Caspase-3 (P=0.026)). The changes were not significant in b-FGF (P=0.087), Bmp-2 (P=0.457), TGF-β1 (P=0.201) and PDGFR-α (P=0.116) genes compared to control. Smad1 gene mRNA expression was not detected in all groups.

Histopathological results

Histopathology results of lung tissue classify by Takhtfooladi et al (2015) criteria (17). According to this classification; Grade 0: Normal structure; Grade 1: Mild neutrophil leukocyte infiltration and mild to moderate interstitial congestion; Grade 2: Moderate neutrophil leukocyte infiltration, perivascular edema, and local destruction of pulmonary architecture; and Grade 3: Intensive neutrophil leukocyte infiltration and complete destruction of pulmonary structure. The histological examination of the lungs of the groups shown in Table 1.
Table 1

Histopathologic evaluation in lung tissue for each group

GroupsControlII/2 RI/4 RP
Histological score0.00 ± 0.00 [d]1.30 ± 0.15 [c]1.80 ± 0.20 [b]2.60 ± 0.16 [a]0.001

Means within each row with different superscripts are statistically important

Histopathologic evaluation in lung tissue for each group Means within each row with different superscripts are statistically important Appearance of lung parenchyma tissue is protected in control group (Picture 3).
Picture 3

Control group image. HE staining bar= 50 μm

Control group image. HE staining bar= 50 μm In Group 1 (I), there are more erythrocyte accumulations in alveolar lumens together with severe congestions in pulmonary veins and interalveolar septum, and there are marked thickenings at inter-alveolar septum. In addition to these, mild perivascular neutrophil infiltration is seen in right lobe. There are few and far between desquamations on respiratory passage epithels (Picture 4).
Picture 4

60 min ischemia + 0 min reperfusion group image A) left lobe H-E bar=100 μm B) right lobe H-E Bar= 50 μm

60 min ischemia + 0 min reperfusion group image A) left lobe H-E bar=100 μm B) right lobe H-E Bar= 50 μm In Group 2 (I+2R), in addition to congestive findings, severe perivascular neutrophil, leukocyte infiltrations and intra-alveolar edema are drew attention. Degeneration and desquamation of alveolar epithels are marked, also degeneration and desquamation are identified on bronchi and bronchiole epitheliums. In right lobe, mild edema as well as severe congestive changes are observed. There are necrotic changes on alveolar and bronchiole epitheliums (Picture 5).
Picture 5

0 min ischemia + 120 min reperfusion group image A) left lobe H-E bar= 50 μm B) right Lobe H-E bar= 50 μm

0 min ischemia + 120 min reperfusion group image A) left lobe H-E bar= 50 μm B) right Lobe H-E bar= 50 μm In all member of Group 3 (I+4R), congestive atelectasis in varying severity is formed. Also, marked alveolar macrophages hyperplasia is present in alveolar lumen as well as neutrophil, leukocyte infiltrations and perivascular edema. The presence of severe necrotic changes on alveolar epithelium and desquamation on bronchiolar epithelial draw attention. Edematous and congestive changes in right lobe come into focus (Picture 6).
Picture 6

60 min ischemia + 240 min reperfusion group image A) left lobe H-E bar= 100 μm B) right Lobe H-E bar= 50 μm

60 min ischemia + 240 min reperfusion group image A) left lobe H-E bar= 100 μm B) right Lobe H-E bar= 50 μm

Discussion

Ischemia-reperfusion induced acute lung injury is the main reason of early morbidity and mortality after lung transplantation (18). Ischemia reperfusion injury cause severe inflammation, endothelium damage, neutrophil infiltration and pulmonary edema in lung (4). Ischemia start a series of events include increased microvascular permeability, increased pulmonary vascular resistance, pulmonary edema, distorted oxygenation and pulmonary hypertension (6). The most severe damage happened in the slide perfused 240 min shows that damage in tissue increases as long as reperfusion time increase. So the pathological examinations show us there is a direct proportions between reperfusion time and tissue damage. Caspases are important mediators for apoptosis (19). When ischemia occurred in the lung tissue, FAS-L ligands to FAS receptors to activate Caspase-8 binds. Active Caspase-8 proteolytic cleavage and activates Caspase-3, -6 and -7 (executioner caspases) (6). In the present study, the reason of increased the Caspase-3 expression is this mechanism. Forgiarini et al (18) and Zhang et al (20) reported increased Caspase-3 expression in a rat model of I/R group, consistent with us. Caspase-3 expression significantly increased only in group 1 compared to control group. This lead us think that reperfusion may suppress intracellular stress induce Caspase-3 expression. Bcl-XL, member of B-cell lymphoma 2 (Bcl-2) family, is well-known apoptosis controller gene (11). In our study, while Bcl-XL expression significantly increased in group 1, dramatically decreased in group 2 and group 3. Considering the histopathological results and these attitudes of Bcl-XL and Caspase-3, it is seen that reperfusion directed the cell to necrosis instead of apoptosis. Zhang et al (21) recorded I/R induced Bcl-2 and Caspase-3 expressions, consistent with our study. We also found increased expressions of Caspase-3 and Bcl-XL in same group with Bcl-2 in group 1. Bmp-2 inhibits migration and differentiation of lung fibroblast cells (22). Bmp-2 and high homology Bmp-4 are required for normal embryonic development. Bmp-2/4 show functions, such as necessary morphogen in lung development (23). Smad1, 5, 8 are activated by Bmp receptors, Smad2, 3 are activated by TGF-β or activin (24). We reported Bmp-2 gene expression statistically was not change in any group compared to the control. The reason of this may be no activated Smad1 gene. There are no sufficient amount of studies on the effectiveness of Smad1 and Bmp-2 in the lung ischemia reperfusion damage. While bFGF is stored in an inactive form in endothelial cells with heparin, TGF-β is stored in macrophages and platelets and is released here. Both growth factors are included in the process of tissue regeneration and in the restructuring of the capillaries by their mitogenic and non-mitogenic effects (25). In the present study, when the expression of TGF-β compared to the control group recorded any statistically significant changes. However, as long as reperfusion time increase, TGF-β expression was decreased even if statistically insignificant. This may show increase increased reperfusion period is associated with the reduction of TGF-β expression. b-FGF is a growth factor stimulates mesenchymal and epithelial cells and play role in angiogenesis (26). b-FGF has also antiapoptotic effects (27). Sage et al. (27) in their study on piglets have found no changes in the b-FGF gene expression, consistent with our data. Absence of significant changes of b-FGF gene shows that cells cannot run away from cell death in stress condition not only ischemia caused but also reperfusion caused. Light ischemia induces the expression of endogenous factors, and this makes the growth factors participate in the healing tissue (25). In our study, b-FGF and TGF-β expressions increased in ischemia (I) group, but not statistically significant. This reason may be on the basis of the increase occurred. Besides, we see significantly unchanged PDGFR-α expression any group compared to control. These findings can show that the reperfusion time is not effective on PDGFR-α expression. When the literature is reviewed, this study is the first one shows PDGFR-α expression in a rat model of I/R.

Conclusion

The findings of our study show that ischemia reperfusion injury may trigger apoptotic mechanism in lung.
  27 in total

1.  N-acetylcysteine administration confers lung protection in different phases of lung ischaemia-reperfusion injury.

Authors:  Luiz Felipe Forgiarini; Luiz Alberto Forgiarini; Darlan Pase da Rosa; Mariel Barbachan E Silva; Rodrigo Mariano; Artur de Oliveira Paludo; Cristiano Feijó Andrade
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-08-24

2.  [Protective effect of N-acetylcysteine against pneumocyte apoptosis during ischemia/reperfusion injury of lung in rats].

Authors:  Zheng Zhang; Huau Shen; Hai-dong Qin; Ying Xu; Ming-zhou Ma; Lei Bao; Hong Wang
Journal:  Zhongguo Wei Zhong Bing Ji Jiu Yi Xue       Date:  2012-02

3.  Melatonin attenuates lung injury in a hind limb ischemia-reperfusion rat model.

Authors:  Hamed Takhtfooladi; Mohammad Takhtfooladi; Fariborz Moayer; Sayed Mobarakeh
Journal:  Rev Port Pneumol (2006)       Date:  2015-01-20

Review 4.  Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process.

Authors:  Willem A den Hengst; Jan F Gielis; Judy Y Lin; Paul E Van Schil; Leon J De Windt; An L Moens
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-10       Impact factor: 4.733

Review 5.  Role of exercise training on pulmonary ischemia/reperfusion and inflammatory response.

Authors:  Maria Andréia Delbin; Edson Antunes; Angelina Zanesco
Journal:  Rev Bras Cir Cardiovasc       Date:  2009 Oct-Dec

6.  BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis.

Authors:  E H Cheng; M C Wei; S Weiler; R A Flavell; T W Mak; T Lindsten; S J Korsmeyer
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

Review 7.  Emerging roles of caspase-3 in apoptosis.

Authors:  A G Porter; R U Jänicke
Journal:  Cell Death Differ       Date:  1999-02       Impact factor: 15.828

Review 8.  Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy.

Authors:  Rajesh N Gacche; Rohan J Meshram
Journal:  Biochim Biophys Acta       Date:  2014-05-13

Review 9.  Targeting the PDGF signaling pathway in tumor treatment.

Authors:  Carl-Henrik Heldin
Journal:  Cell Commun Signal       Date:  2013-12-20       Impact factor: 5.712

10.  Endothelial cell apoptosis in chronically obstructed and reperfused pulmonary artery.

Authors:  Edouard Sage; Olaf Mercier; Frederic Van den Eyden; Marc de Perrot; Anne Marie Barlier-Mur; Philippe Dartevelle; Saadia Eddahibi; Philippe Herve; Elie Fadel
Journal:  Respir Res       Date:  2008-02-12
View more
  2 in total

1.  Bag-1L Protects against Cell Apoptosis in an In Vitro Model of Lung Ischemia-Reperfusion Injury through the C-Terminal "Bag" Domain.

Authors:  Ji-Ling Lv; Li-Na Shi; Cong-Ying Zhai; Ge-Jin Wang; Yan Qu
Journal:  Biomed Res Int       Date:  2021-03-17       Impact factor: 3.411

2.  Silencing Huwe1 reduces apoptosis of cortical neurons exposed to oxygen-glucose deprivation and reperfusion.

Authors:  Guo-Qian He; Wen-Ming Xu; Hui-Juan Liao; Chuan Jiang; Chang-Qing Li; Wei Zhang
Journal:  Neural Regen Res       Date:  2019-11       Impact factor: 5.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.